期刊文献+
共找到7篇文章
< 1 >
每页显示 20 50 100
利福平对小鼠的肝毒性及胆酸代谢基因的影响 被引量:9
1
作者 徐永吉 李文楷 +1 位作者 刘杰 陆远富 《中国药理学通报》 CAS CSCD 北大核心 2016年第6期841-845,共5页
目的观察利福平长期给药引起小鼠的肝损伤及其对胆汁酸代谢通路相关基因的影响。方法 1 d 1次灌胃给予♂昆明种小鼠180 mg·kg^(-1)利福平连续30 d与90 mg·kg^(-1)利福平连续90 d;麻醉取血、肝脏,称肝重,检测血清谷丙转氨酶(AL... 目的观察利福平长期给药引起小鼠的肝损伤及其对胆汁酸代谢通路相关基因的影响。方法 1 d 1次灌胃给予♂昆明种小鼠180 mg·kg^(-1)利福平连续30 d与90 mg·kg^(-1)利福平连续90 d;麻醉取血、肝脏,称肝重,检测血清谷丙转氨酶(ALT),观察肝脏组织的病理变化;提取肝脏总RNA并采用RT-PCR法检测胆汁酸代谢相关基因mRNA的表达情况,提取肝脏总蛋白并采用Western blot法检测相关蛋白的表达。结果连续给予利福平180 mg·kg^(-1)30 d和90 mg·kg^(-1)90 d,小鼠肝重系数增加,肝脏发生明显病理改变,表现为肝细胞水肿、羽毛样变性与脂肪变性,且利福平180 mg·kg^(-1)30 d病理改变较严重;连续给药180 mg·kg^(-1)利福平30 d可使胆酸代谢基因胆固醇7α-羟化酶(CYP7A1)、法尼醇受体(FXR)、小分子异源二聚体伴侣(SHP)表达增加,胆盐输出泵(BSEP)的表达降低;连续给药90 mg·kg^(-1)利福平90 d,仅可发现胆酸代谢基因胆固醇7α-羟化酶(CYP7A1)表达增加。结论利福平对小鼠具有明显肝毒性,引起胆汁淤积性肝损伤;其影响CYP7A1与BSEP的基因表达可能是其导致胆汁淤积性肝损伤的机制之一。 展开更多
关键词 利福平 肝毒性 胆酸代谢 胆汁淤积 CYP7A1 BSEP
下载PDF
梗阻性黄疸患者胆汁引流前后胆酸代谢的变化 被引量:2
2
作者 李冰 沈魁 《中华实验外科杂志》 CAS CSCD 北大核心 1992年第1期46-46,共1页
关键词 梗阻性黄疸 胆汁 引流 胆酸代谢
原文传递
还原型谷胱甘肽治疗酒精性脂肪肝46例观察 被引量:2
3
作者 刘三都 杨庆坤 《实用中医药杂志》 2004年第9期540-540,共1页
关键词 还原型谷胱甘肽 酒精性脂肪肝 血脂 毒性代谢 胆酸代谢
下载PDF
Endocrine and paracrine role of bile acids 被引量:9
4
作者 Verena Keitel Ralf Kubitz Dieter Hussinger 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第37期5620-5629,共10页
Bile acids are not only important for the absorption of dietary lipids and fat soluble vitamins but are signalling molecules with diverse endocrine and paracrine functions. Bile acids regulate bile acid, lipid and glu... Bile acids are not only important for the absorption of dietary lipids and fat soluble vitamins but are signalling molecules with diverse endocrine and paracrine functions. Bile acids regulate bile acid, lipid and glucose metabolism and modulate temperature and energy homeostasis. Furthermore, bile acids can not only promote cell proliferation and liver regeneration but can also induce programmed cell death. Bile acid functions are mediated through different pathways which comprise the activation of nuclear hormone receptors, of intracefular kinases and of the plasma membranebound, G-protein coupled bile acid receptor TGRS/Gpbar-1. 展开更多
关键词 Bile acids Farnesoid X receptor TGR5 Glucose metabolism Lipid metabolism
下载PDF
Regulation of Acyl-coenzyme A:Cholesterol Acyltransferase 2 Expression by Saturated Fatty Acids 被引量:4
5
作者 Zhu-qin Zhang Hou-zao Chen Rui-feng Yang Ran Zhang Yu-yan Jia Yang Xi De-pei Liu Chih-chuan Liang 《Chinese Medical Sciences Journal》 CAS CSCD 2010年第4期222-227,共6页
Objective To verify the regulation of acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT 2), which is associated with cholesterol metabolism, by saturated fatty acids (SFAs). Methods Palmitic acid (PA), the most abun... Objective To verify the regulation of acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT 2), which is associated with cholesterol metabolism, by saturated fatty acids (SFAs). Methods Palmitic acid (PA), the most abundant saturated fatty acid in plasma, and oleic acid (OA), a widely distributed unsaturated fatty acid, were used to treat hepatic cells HepG2, HuH7, and mouse primary hepatocytes. In addition, PA at different concentrations and PA treatment at different durations were applied in HepG2 cells. In in vivo experiment, three-month male C57/BL6 mice were fed with control diet and SFA diet containing hydrogenated coconut oil rich of SFAs. The mRNA level of ACAT2 in those hepatic cells and the mouse livers was detected with real-time polymerase chain reaction (PCR). Results In the three types of hepatic cells treated with PA, that SFA induced significant increase of ACAT2 expression (P<0.01), whereas treatment with OA showed no significant effect. That effect of PA was noticed gradually rising along with the increase of PA concentration and the extension of PA treatment duration (both P<0.05). SFA diet feeding in mice resulted in a short-term and transient increase of ACAT2 expression in vivo, with a peak level appearing in the mice fed with SFA diet for two days (P<0.05). Conclusion SFA may regulate ACAT2 expression in human and mouse hepatic cells and in mouse livers. 展开更多
关键词 acyl-coenzyme A:cholesterol acyltransferase 2 gene expression saturatedfatty acid
下载PDF
liver and the defects of cholesterol and bile acids biosynthesis: rare disorders many diagnostic pitfalls 被引量:2
6
作者 Gaetano Corso Antonio Dello Russo Monica Gelzo 《World Journal of Gastroenterology》 SCIE CAS 2017年第29期5257-5265,共9页
In recent decades, biotechnology produced a growth of knowledge on the causes and mechanisms of metabolic diseases that have formed the basis for their study, diagnosis and treatment. Unfortunately, it is well known t... In recent decades, biotechnology produced a growth of knowledge on the causes and mechanisms of metabolic diseases that have formed the basis for their study, diagnosis and treatment. Unfortunately, it is well known that the clinical features of metabolic diseases can manifest themselves with very different characteristics and escape early detection. Also, it is well known that the prognosis of many metabolic diseases is excellent if diagnosed and treated early. In this editorial we briefly summarized two groups of inherited metabolic diseases, the defects of cholesterol biosynthesis and those of bile acids. Both groups show variable clinical manifestations but some clinical signs and symptoms are common in both the defects of cholesterol and bile acids. The differential diagnosis can be made analyzing sterol profiles in blood and/or bile acids in blood and urine by chromatographic techniques(GC-MS and LC-MS/MS). Several defects of both biosynthetic pathways are treatable so early diagnosis is crucial. Unfortunately their diagnosis is made too late, due either to the clinical heterogeneity of the syndromes(severe, mild and very mild) that to the scarcity of scientific dissemination of these rare diseases. Therefore, the delay in diagnosis leads the patient to the medical observation when the disease has produced irreversible damages to the body. Here, we highlighted simple clinical and laboratory descriptions that can potentially make you to suspect a defect in cholesterol biosynthesis and/or bile acids, as well, we suggest appropriate request of the laboratory tests that along with common clinical features can help to diagnose these defects. 展开更多
关键词 CHOLESTEROL Bile acids Liver metabolism Gas chromatography coupled to mass spectrometry Liquid chromatography coupled to tandem mass spectrometry
下载PDF
Bile-ology: from bench to bedside 被引量:2
7
作者 Li-hua JIN Zhi-peng FANG +1 位作者 Min-jie FAN Wen-dong HUANG 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2019年第5期414-427,共14页
Bile acids(BAs)are originally known as detergents essential for the digestion and absorption of lipids.In recent years,extensive research has unveiled new functions of BAs as gut hormones that modulate physiological a... Bile acids(BAs)are originally known as detergents essential for the digestion and absorption of lipids.In recent years,extensive research has unveiled new functions of BAs as gut hormones that modulate physiological and pathological processes,including glucose and lipid metabolism,energy expenditure,inflammation,tumorigenesis,cardiovascular disease,and even the central nervous system in addition to cholesterol homeostasis,enterohepatic protection and liver regeneration.BAs are closely linked with gut microbiota which might explain some of their crucial roles in organs.The signaling actions of BAs can also be mediated through specific nuclear receptors and membranebound G protein-coupled receptors.Several pharmacological agents or bariatric surgeries have demonstrated efficacious therapeutic effects on metabolic diseases through targeting BA signaling.In this mini-review,we summarize recent advances in bile-ology,focusing on its translational studies. 展开更多
关键词 Bile acid Gut microbiota Farnesoid X receptor G protein-coupled bile acid receptor Metabolic disease
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部